Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Viiv
Pharma
GSK bolsters case for long-acting HIV PrEP drug Apretude
With GSK girding for competition from Gilead, the company has presented strong results from three real-world studies of HIV prevention drug Apretude.
Kevin Dunleavy
Oct 16, 2024 1:26pm
New name takes top spot in US patient group reputation ranking
May 14, 2024 10:54am
Pharma's reputation falls as pandemic-era halo slips
Apr 29, 2024 2:00am
Arbitration win over J&J gives Alkermes a $425M boost
Jun 6, 2023 3:23pm
GSK adds Karamo Brown to celebs spreading the word about PrEP
Aug 10, 2022 10:13am
Johnson & Johnson refreshes 'Positively Fearless' HIV campaign
Jun 29, 2022 12:41pm
